Bupropion SR for Treating Smokeless Tobacco Use

Completed · Phase 3

Conditions studied: Smokeless Tobacco

In brief

To determine the efficacy and safety of bupropion SR for quitting tobacco in smokeless tobacco users.

Key facts

Study ID

NCT00414180

Run by

Mayo Clinic

People needed

225

Starts

2003-08-01

Expected to finish

2005-05-01

Last updated by the study team

2011-03-14

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• 18 years of age or older
• used ST daily for at least one year
• in good general health
• willing to complete all study procedures

Where it is running

• Mayo Clinic — Rochester, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.